Oral care planning and handling of immunosuppressed heart, liver, and kidney transplant patients

Special Care in Dentistry

Volumn 16, Issue 6, 1996, Pages 242-246

  Somacarrera, Maria Luísa ^a   Lucas, Míguel ^a   Cuervas Mons, Valentín ^b   Hernandez, Gonzalo ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; DENTAL CARE; HEART TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; METHODOLOGY; MIDDLE AGED; NEWBORN; PATIENT CARE PLANNING; POSTOPERATIVE CARE; PREOPERATIVE CARE; PRESCHOOL CHILD; PREVENTIVE DENTISTRY;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DENTAL CARE FOR CHRONICALLY ILL; DENTAL PROPHYLAXIS; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MIDDLE AGED; PATIENT CARE PLANNING; POSTOPERATIVE CARE; PREOPERATIVE CARE;

EID: 0030274855     PISSN: 02751879     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1754-4505.1996.tb01547.x     Document Type: Article

References (24)

1. Organizatión Nacional de Trasplantes de España. Estudio estadístico de trasplante de órganos. Boletín Organización Nacional de Trasplantes, Madrid, España, 1996.
2. Caraceni P, Fagivol S, Wright HI, Nadir A, Van Thiel DH. Gastrointestinal complications of liver transplantation. Ital J Gastroenterol 27:29-39, 1995.
3. HennyFC,Kootte AMM,Van Bockel JH. A prospective randomized comparative study on the influence of cyclosporin and azathioprine on renal allograft survival and function. Nephrol Dial Transplant 1:44-9, 1986.
4. Hall BM, Tiller DJ, Hardie I. Comparison of three immunosuppressive regimens in cadaver renal transplantation: Long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N EngI J Med 318:1499-507, 1988.
5. Heimdahl A, Mattsson T, Dahllof G, Lonnquist B, Ringden O. The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation. Oral Surg Oral Med Oral Pathol 68:711-6, 1989.
6. Britt RH, Enzmann DR, Remington JS. Intracranial infection in cardiac transplant recipients. Ann Neurol 9:107-19, 1981.
7. Socransky SS. Microbiology of periodontal disease, present status and future considerations. J Periodontol 48:485-9, 1971.
8. Navazesh M, Mulligan R. Systemic dissemination as a result of oral infection in individuals 50 years of age and older. Spec Care Dentist 15:11-9, 1995.
9. Colonna KO, Winston DJ, Brill JE, Goldstein LI, Hoff MP, Hiatt JR, et al. Infectious complications in liver transplantation. Arch Surg 123:360-4, 1988.
10. Nieto-Rodriguez JA, Kusne S, Manez R, Irish W, Linden P, Magnone M, et al. Factors associated with the development of candidemia and candidemia-related death among liver transplant recipients. Ann Surg 223:70-6, 1996.
11. Land W, editor. An attempt at evaluation of current internationally used protocols. In: Optimal use of Sandimmun in organ transplantation. Berlin: Springer-Verlag, pp. 1-19, 1987.
12. Sandoz Ltd. Sandimmun (Cyclosporin) Practical Guide. Basel, Switzerland, pp. 35-8,1989.
13. Cuervas V. Trasplante hepático. Información terapéutica del sistema nacional de salud. 14:137-44, 1990.
14. Somacarrera ML, Hemández G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 65:671-5, 1994.
15. Dajani AS, Bisno AL, Chung KJ. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. J Am Med Assoc 264:2919-22, 1990.
16. O'Leary TJ, Drake RB, Naylord JE. The plaque control record. J Periodontol 43:38, 1972.
17. Lenox JA, Kopczyk RA. A clinical system for scoring a patient's oral hygiene performance. J Am Dent Assoc 86:849-52, 1978.
18. Harris TH, Ewalt JR. Complication following the use of sodium diphenylhydantoinate (Dilantin) therapy. J OK State Med Assoc 9:365-70, 1942.
19. Bricker SL, Langlais RP, Miller CS. Oral diagnosis, oral medicine, treatment planning. Vol. 14. Malvem, PA: Lea&Febiger, pp. 361-420, 1994.
20. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporine induced gingival changes. J Clin Periodontol 18:107-10, 1991.
21. Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin A. Br Dent J 157:305-9, 1984.
22. Daley TD, Wycoski GP, Day C. Clinical and pharmacological correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 62:414-21, 1986.
23. Dahllöf G, Modéer T. The effect of plaque control program on the development of phenytoin-induced gingival overgrowth. J Clin Periodont 13:845-6, 1986.
24. Endocarditis Working Party of the British Society for Antimicrobial Chemotherapy. Antibiotic prophylaxis of infective endocarditis. Lancet 1:88-9, 1990.